Cite
MLA Citation
Christophe Hézode et al.. “Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.” Liver international, vol. 37, 2017, pp. 1314–1324. http://access.bl.uk/ark:/81055/vdc_100049405722.0x000030